Learn about the new features incorporated into the latest release of the Simcyp Population-based Simulator, which streamlines drug development through the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual populations.
Mounting healthcare and R&D costs, high drug attrition rates leading to decreased numbers of new molecular entity approvals, and growing demands from regulators and payers indicate that a paradigm shift is needed to improve efficiency and productivity across the drug development continuum.
MELBOURNE, AUSTRALIA – 10월 26, 2017 – MTPConnect today announced it will provide provisional funding to the Certara-Monash University Industry Fellowship Program over two years, with proposed matched funding coming from Certara.
PRINCETON, NJ – Oct. 13, 2017 – Certara today announced that it is participating in 27 sessions at the eighth American Conference on Pharmacometrics (ACoP8).
